Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
UCB plans to submit regulatory applications in Q3 2022
Subscribe To Our Newsletter & Stay Updated